Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide with Active Vitamin D and Calcium in Osteoporosis (Serum Calcium Effects)
jRCT1080221547Phase 4
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of teriparatide in osteoporosis, sponsored by Eli Lilly and Company. Primary endpoint: Serum calcium changes with teriparatide plus active vitamin D.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on jRCT1080221547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080221547.